Oscar Wilde knew all about conflicts of interest, whether he realised it or not. His play The Ideal Husband highlights a conflicted individual taking advantage of sensitive information for personal gain. Whether or not Wilde would have been in a position to write the current NZX policy settings related to Director Independence is a different…
Read more
Annual Meeting Report, 30th June 2023 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 (restated) 2022 Change Revenue $0.1m $0.2m $0.1m -32% NPAT -$3.5m -$3.1m -$8.2m n/a Gross Margin n/a 36% n/a n/a Inventory Turnover n/a 9.84 n/a n/a EPS -$0.029 -$0.021 -$0.056 n/a PE Ratio n/a n/a n/a n/a Capitalisaion $39.9m…
Read more
Annual Meeting Report, 7th June 2023 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 2022 Change Revenue $470.7m $514.6m $619.1m 20% EBITDA $56.7m $71.6m $68.5m -4% NPAT2 $21.0m $26.9m 19.4m -28% Gross Profit Margin 22% 22% 20% -8% Inventory Turnover 7.50 7.70 8.07 5% EPS12 $0.148 $0.189 $0.136 -28% PE Ratio 31…
Read more
Annual Meeting Report, 23rd June 2023 Click here for NZSA Assessment and Voting intentions Metric 2021 (period) 2022 2023 (6 Months) Change Rental Income $498k $8.2m $5.7m n/a EBITDA -$1.8m $2.6m $4.2m n/a NPAT $15.1m $39.7m $5.3m n/a Change in value prop $16.5m $35.3m $2.3m n/a EPS1 $0.191 $0.343 $0.038 n/a PE Ratio 6 3…
Read more
Early on June 22nd, EROAD (NZX: ERD) notified the market that it had received a non-binding indicative offer (NBIO) from Toronto-listed Constellation Software (via Australian-based Volaris Group) for the entire company at a value of $1.30 per share. That represents a significant premium to the closing price of prior days trading of $0.77, but does…
Read more
Annual Meeting Report, 21st June 2023 Click here for NZSA Assessment and Voting intentions Metric 2021 2022 2023 Change Revenue $1,413m $1,376m $1,317m -4% NPAT1 $11.1m $8.8m -$0.9m n/a EPS1 $0.091 $0.072 -$0.045 n/a PE Ratio 32 39 n/a Capitalisation $348m $252m -27% Current Ratio 1.39 1.40 1.56 11% Debt Equity 0.89 0.72 0.88 23%…
Read more
In recent weeks, the Michael Wood saga has been well-covered by local media. Scratch below the surface, however, and there is a clear impact on the interests of investors from unconscious bias in the rhetoric that has since emerged. As investors and New Zealanders, we need MP’s to understand capital markets. Their active participation in…
Read more
Annual Meeting Report, 20th June 2023 Click here for NZSA Assessment and Voting intentions Metric 2021 2022 2023 Change Operating Revenue $133.5m $131.6m $144.5m 10% Revaluations Gains $157.6m $163.6m -$146.5m n/a NPAT $241.7m $236.1m -$80.8m n/a EPS1 $0.288 $0.279 -$0.095 n/a PE Ratio 5 4 n/a Capitalisation $1,050m $923m -12% Current Ratio 4.97 1.10 0.56…
Read more
Annual Meeting Report, 14th June 2023 Click here for NZSA Assessment and Voting intentions Metric 2020 2021 2022 Change Revenue $172m $164.8m $144.2m -12% Hotel Revenue $64.1m $55.2m $65.2m 18% NPAT1 $46.0m $40.0m $21.7m -46% EPS1 $0.29 $0.253 $0.137 -46% PE Ratio 8 9 16 Capitalisation $266m $226m -15% Current Ratio 7.97 5.9 6.78 15%…
Read more
Announcements regarding capital markets policy rarely incite much excitement amongst retail investors. Whether you’re experienced or inexperienced as an investor, it can be hard to relate to the introspective, jargon-filled discussions that create the rules of the game when it comes to investing in New Zealand’s public capital markets. It’s ironic, really, when you consider…
Read more
